10 November 2026•1 min read•EkoDemy Academic Desk

Revised MRPs of 1,364 Anti-Cancer Formulations Now in Force: 679 Brands Cut Prices by Over 50%, Savings of ₹3,540 Crore a Year

Update, 9 Nov 2026: 85 companies reported revised MRPs for 1,364 anti-cancer formulations (121 drugs) under NPPA's trade-margin cap; estimated annual savings ₹3,540.38 crore.

Share this study resourceSpread the word with your peers & study groups
Revised MRPs of 1,364 Anti-Cancer Formulations Now in Force: 679 Brands Cut Prices by Over 50%, Savings of ₹3,540 Crore a Year | EkoDemy Free Resources